Mycobacterium scrofulaceum

{{Speciesbox

| taxon = Mycobacterium scrofulaceum

| authority = Prissick and Masson 1956

| synonyms =

}}

Mycobacterium scrofulaceum is a species of Mycobacterium.{{cite journal |doi=10.1002/jcla.20278 |pmid=19021271 |title=Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans |journal=Journal of Clinical Laboratory Analysis |volume=22 |issue=6 |pages=415–20 |year=2008 |last1=Ryoo |first1=Sung Weon |last2=Shin |first2=Sonya |last3=Shim |first3=Myung-Shup |last4=Park |first4=Yoon-Sung |last5=Lew |first5=Woo Jin |last6=Park |first6=Sue-Nie |last7=Park |first7=Young Kil |last8=Kang |first8=Seongman |pmc=6649107 }}

It is the most common cause of mycobacterial cervical lymphadenitis in children.{{EMedicine|article|1105570|Atypical Mycobacterial Diseases}}

It is sometimes included in the "MAIS group" with Mycobacterium avium and Mycobacterium intracellulare.{{cite journal |doi=10.1128/AEM.69.9.5685-5689.2003 |pmid=12957962 |pmc=194915 |title=Factors Influencing the Chlorine Susceptibility of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum |journal=Applied and Environmental Microbiology |volume=69 |issue=9 |pages=5685–9 |year=2003 |last1=Falkinham |first1=J. O. }}

Treatment

Due to the rarity of infection, no prospective studies have been undertaken and therefore treatment choices remain somewhat controversial. For childhood infection, surgery is the recommended treatment, in which the lesion is excised without chemotherapy. The success rate for this treatment is 95%.{{cite journal |doi=10.1164/rccm.200604-571ST |pmid=17277290 |title=An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases |journal=American Journal of Respiratory and Critical Care Medicine |volume=175 |issue=4 |pages=367–416 |year=2007 |last1=Griffith |first1=David E. |last2=Aksamit |first2=Timothy |last3=Brown-Elliott |first3=Barbara A. |last4=Catanzaro |first4=Antonino |last5=Daley |first5=Charles |last6=Gordin |first6=Fred |last7=Holland |first7=Steven M. |last8=Horsburgh |first8=Robert |last9=Huitt |first9=Gwen |last10=Iademarco |first10=Michael F. |last11=Iseman |first11=Michael |last12=Olivier |first12=Kenneth |last13=Ruoss |first13=Stephen |last14=von Reyn |first14=C. Fordham |last15=Wallace |first15=Richard J. |last16=Winthrop |first16=Kevin |author17=ATS Mycobacterial Diseases Subcommittee |last18=American Thoracic |first18=Society |author19=Infectious Disease Society of America }} Drugs which are used in treatment of Mycobacterium scrofulaceum include isoniazid, rifampin and streptomycin.

References

External links

[http://bacdive.dsmz.de/index.php?search=8369&submit=Search Type strain of Mycobacterium scrofulaceum at BacDive - the Bacterial Diversity Metadatabase]

scrofulaceum